Financhill
Buy
60

KOD Quote, Financials, Valuation and Earnings

Last price:
$24.69
Seasonality move :
0.15%
Day range:
$21.51 - $23.45
52-week range:
$1.92 - $23.63
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
51.41x
Volume:
686K
Avg. volume:
779.2K
1-year change:
215.82%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$4.12

Analysts' Opinion

  • Consensus Rating
    Kodiak Sciences, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 2 Hold ratings, and 1 Sell rating.
  • Price Target Downside
    According to analysts' consensus price target of $21.29, Kodiak Sciences, Inc. has an estimated downside of -7.29% from its current price of $22.96.
  • Price Target Upside
    According to analysts, the highest upside price target is $40.00 representing -100% upside increase from its current price of $22.96.

Fair Value

  • According to the consensus of 7 analysts, Kodiak Sciences, Inc. has -7.29% downside to fair value with a price target of $21.29 per share.

KOD vs. S&P 500

  • Over the past 5 trading days, Kodiak Sciences, Inc. has underperformed the S&P 500 by -0.14% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Kodiak Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kodiak Sciences, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Kodiak Sciences, Inc. reported revenues of --.

Earnings Growth

  • Kodiak Sciences, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Kodiak Sciences, Inc. reported earnings per share of -$1.16.
Enterprise value:
1.3B
EV / Invested capital:
7.04x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.43x
EV / Free cash flow:
-10.28x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$26.5M
Return On Assets:
-73.38%
Net Income Margin (TTM):
--
Return On Equity:
-201.8%
Return On Invested Capital:
-78.9%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -$22.6M -$26.7M -$26.5M -$6.7M -$6.5M
Operating Income -$288M -$204M -$221.2M -$46.6M -$62.4M
EBITDA -$265.4M -$177.4M -$194.7M -$39.9M -$55.8M
Diluted EPS -$5.18 -$3.65 -$4.12 -$0.84 -$1.16
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $805.5M $544.7M $350.9M $202.5M $75.7M
Total Assets $958.2M $724M $547.7M $372.7M $218.1M
Current Liabilities $54.4M $65.6M $70.8M $24.1M $42.4M
Total Liabilities $231.9M $244.5M $245.2M $187.3M $194.4M
Total Equity $726.3M $479.5M $302.4M $185.4M $23.7M
Total Debt $178.9M $178.7M $174.5M $163.2M $150.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$177M -$119.5M -$126.7M -$21.2M -$32.9M
Cash From Investing $344M -$28.4M -$587K -$205K -$60K
Cash From Financing $252K -$27K $1.5M -- $813K
Free Cash Flow -$196.6M -$147.2M -$127.3M -$21.4M -$32.9M
KOD
Sector
Market Cap
$1.2B
$28.4M
Price % of 52-Week High
97.17%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
0.14%
-1.32%
1-Year Price Total Return
215.82%
-22.19%
Beta (5-Year)
2.684
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $22.24
200-day SMA
Buy
Level $8.44
Bollinger Bands (100)
Buy
Level 8.04 - 18.42
Chaikin Money Flow
Buy
Level 14.8M
20-day SMA
Buy
Level $20.26
Relative Strength Index (RSI14)
Buy
Level 64.81
ADX Line
Buy
Level 33.35
Williams %R
Sell
Level -12.0072
50-day SMA
Buy
Level $17.78
MACD (12, 26)
Buy
Level 1.50
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 22.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-5.1586)
Sell
CA Score (Annual)
Level (-2.4847)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.5597)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Stock Forecast FAQ

In the current month, KOD has received 4 Buy ratings 2 Hold ratings, and 1 Sell ratings. The KOD average analyst price target in the past 3 months is $21.29.

  • Where Will Kodiak Sciences, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kodiak Sciences, Inc. share price will drop to $21.29 per share over the next 12 months.

  • What Do Analysts Say About Kodiak Sciences, Inc.?

    Analysts are divided on their view about Kodiak Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kodiak Sciences, Inc. is a Sell and believe this share price will rise from its current level to $2.00.

  • What Is Kodiak Sciences, Inc.'s Price Target?

    The price target for Kodiak Sciences, Inc. over the next 1-year time period is forecast to be $21.29 according to 7 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is KOD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kodiak Sciences, Inc. is a Buy. 4 of 7 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of KOD?

    You can purchase shares of Kodiak Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kodiak Sciences, Inc. shares.

  • What Is The Kodiak Sciences, Inc. Share Price Today?

    Kodiak Sciences, Inc. was last trading at $24.69 per share. This represents the most recent stock quote for Kodiak Sciences, Inc.. Yesterday, Kodiak Sciences, Inc. closed at $22.96 per share.

  • How To Buy Kodiak Sciences, Inc. Stock Online?

    In order to purchase Kodiak Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock